Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

Launched by AZIENDA SANITARIA-UNIVERSITARIA INTEGRATA DI UDINE · Aug 31, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new tool called an ultrathin bronchoscope (UB) to help doctors diagnose lung problems, specifically in hard-to-reach areas of the lungs known as peripheral lung lesions. The trial aims to see how well this device works when combined with advanced imaging techniques like fluoroscopy and ultrasound to guide the procedure. It’s important because using this ultrathin tool can make the procedure quicker and may improve the ability to gather tissue samples needed to identify conditions such as lung cancer or other lung diseases.

To participate in the trial, patients must be adults aged 65 and older who are candidates for a procedure to diagnose a new lung lesion or to take another sample from a previously examined lesion. They also need to be able to understand the study and provide consent. Participants will undergo a safe procedure where doctors use the ultrathin bronchoscope and imaging guidance to collect tissue samples. If you’re interested in learning more or think you might qualify, it’s best to discuss this with your doctor.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Candidate for a diagnostic procedure for a new peripheral lung lesion or re-biopsy;
• • Tissue sampling of the peripheral lesion performed only with UB;
• • The patient's ability to understand the individual characteristics and consequences of the clinical study;
• • Males and females of any ethnicity;
• • Subjects who have given their informed consent to use their clinical data for research purposes.
• Exclusion criteria:
• • Inability to give informed consent or understand its contents;
• • Unavailability of tomographic imaging;
• • Failure to use RP-EBUS or fluoroscopic guidance during the procedure;
• • Failure to use R.O.S.E. by the pulmonologist or pathologist during the procedure;
• • Tissue sampling on the same peripheral lesion using an instrument of a different caliber in replacement or in association;
• • Any other significant illness or disorder that, in the investigator's opinion, may put the patient at risk due to study participation.